Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Drug commercialization

How Patient Advocacy Impacts Drug Commercialization
Posted in
  • Industry Landscape

How Patient Advocacy Impacts Drug Commercialization

Patient advocacy has emerged as a powerful force in shaping the U.S. pharmaceutical market. Advocacy groups, … How Patient Advocacy Impacts Drug CommercializationRead more

by Jayshree Gondane•March 11, 2026March 11, 2026•0
Top 5 Reasons Biotech Companies Fail to Scale
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Regulatory Compliance

Top 5 Reasons Biotech Companies Fail to Scale

Biotechnology has emerged as one of the most innovation-driven sectors in healthcare. Advances in gene therapy, … Top 5 Reasons Biotech Companies Fail to ScaleRead more

by Jayshree Gondane•February 23, 2026February 23, 2026•0
Why Clinical Trial Data Fails to Translate Into Market Success
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Clinical Trial Data Fails to Translate Into Market Success

A therapy can clear Phase III, secure FDA approval, and generate headline optimism-only to miss revenue … Why Clinical Trial Data Fails to Translate Into Market SuccessRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
What Happens When Pharma Ignores Real-World Evidence
Posted in
  • Industry Landscape
  • Strategy & Execution

What Happens When Pharma Ignores Real-World Evidence

In 2023, nearly half of drugs approved by the U.S. Food and Drug Administration faced post-launch … What Happens When Pharma Ignores Real-World EvidenceRead more

by Jayshree Gondane•February 8, 2026February 8, 2026•0
Why Great Science Often Fails Commercially in Pharma
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Great Science Often Fails Commercially in Pharma

In the United States, bringing a new drug to market now costs more than $2 billion on average … Why Great Science Often Fails Commercially in PharmaRead more

by Jayshree Gondane•February 6, 2026February 6, 2026•0

Recent Posts

  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
  • FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know Now
  • The Uncomfortable Truth About Pharmaceutical Marketing Failure
  • The Truth About Pharmaceutical Marketing in the United States

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A